{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T08:40:02Z","timestamp":1737362402429,"version":"3.33.0"},"reference-count":0,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1136\/ard.2010.129643p","type":"journal-article","created":{"date-parts":[[2010,3,9]],"date-time":"2010-03-09T11:52:54Z","timestamp":1268135574000},"page":"A55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"S2","title":["Tumour necrosis factor antagonists and tocilizumab have a higher impact on rheumatoid arthritis osteoclastogenic stimuli than methotrexate"],"prefix":"10.1016","volume":"69","author":[{"given":"I","family":"Perp\u00e9tuo","sequence":"first","affiliation":[]},{"given":"D","family":"Fernandes","sequence":"additional","affiliation":[]},{"given":"R","family":"Casc\u00e3o","sequence":"additional","affiliation":[]},{"given":"R","family":"Moura","sequence":"additional","affiliation":[]},{"given":"J","family":"Caetano-Lopes","sequence":"additional","affiliation":[]},{"given":"A","family":"Rodrigues","sequence":"additional","affiliation":[]},{"given":"J","family":"Polido-Pereira","sequence":"additional","affiliation":[]},{"given":"M","family":"Viana Queiroz","sequence":"additional","affiliation":[]},{"given":"J E","family":"Fonseca","sequence":"additional","affiliation":[]},{"given":"H","family":"Canh\u00e3o","sequence":"additional","affiliation":[]}],"member":"78","container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724445068?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724445068?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2010.129643p","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T08:03:13Z","timestamp":1737360193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724445068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":0,"alternative-id":["S0003496724445068"],"URL":"https:\/\/doi.org\/10.1136\/ard.2010.129643p","relation":{},"ISSN":["0003-4967"],"issn-type":[{"type":"print","value":"0003-4967"}],"subject":[],"published":{"date-parts":[[2010,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumour necrosis factor antagonists and tocilizumab have a higher impact on rheumatoid arthritis osteoclastogenic stimuli than methotrexate","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2010.129643p","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}